Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2

Get the latest international news and world events from around the world.

Log in for authorized contributors

Biohybrid Robots Explained: When Biology Meets Robotics & AI! #BiohybridRobots #SyntheticBiology

/ @lostpagesofscience.
Discover the incredible future of biohybrid robots, the revolutionary fusion of synthetic biology, artificial intelligence, and robotics! In this episode, we explore robots powered by living tissues, capable of self-repair, adaptation, and natural movements. Find out how these bioengineered robots can transform medicine, agriculture, environmental science, and prosthetics. Learn about the ethical considerations, safety challenges, and futuristic possibilities of combining biological materials with robotic systems.

🔔 Don’t forget to subscribe for cutting-edge science & technology content!

📌 Chapters:
00:00 — Introduction to Biohybrid Robots.
01:30 — What Are Biohybrid Robots?
03:50 — How Scientists Build Biohybrid Robots.
06:20 — Medical Applications & Healthcare.
08:45 — Revolutionary Prosthetics.
11:00 — Environmental Biohybrid Robotics.
13:20 — Agricultural Applications.
14:50 — Ethical & Safety Considerations.
17:00 — Future Possibilities.
19:00 — Conclusion & Call to Action.

SEO Keywords:
Biohybrid robots.

Synthetic biology and robotics.

Living robots.

Continue reading “Biohybrid Robots Explained: When Biology Meets Robotics & AI! #BiohybridRobots #SyntheticBiology” | >

The Startup Freezing Humans For Tomorrow — Interview with Dr Emil Kendziorra, CEO of Tomorrow.bio

Join us for a deep-dive conversation with Dr Emil Kendziorra, CEO of Tomorrow.bio, as we explore the cutting edge of cryopreservation and medical biostasis.

Dr Kendziorra, who began his career in cancer research with a summa cum laude degree from the University of Göttingen, shares his remarkable journey from academic science to entrepreneurship, and ultimately to founding Tomorrow.bio — a company he considers his life’s work.

In this interview, he discusses the motivations behind his pivot from traditional longevity research to the frontier of cryomedicine, the operational and emotional lessons learned from cryopreserving over 20 human patients and 10 pets, and his vision for making this technology more accessible in the future.

Tomorrow.bio stands as Europe’s fastest-growing cryopreservation company, with over 800 members across 200+ cities and 45+ countries. The company offers both whole-body cryopreservation and brain-only preservation, using a transparent pricing model designed for long-term value.

With a recent €5 million Seed round and a mission to advance medical biostasis, Emil discusses the unique challenges and opportunities of operating in this space, the ethical considerations of a technology that may not achieve revival for decades, and his long-term vision for the field.

Key Points.

Continue reading “The Startup Freezing Humans For Tomorrow — Interview with Dr Emil Kendziorra, CEO of Tomorrow.bio” | >

A man with terminal glioblastoma was given 12–15 months to live

After four injections of a therapy called Anktiva, his latest scan came back normal.

The treatment has been studied for more than a decade and has shown promise across multiple cancer types, yet it’s only approved for a narrow form of bladder cancer.

Should potentially life-saving treatments move through the approval process faster for patients with no other options?

Age-Related ‘Unraveling’ of DNA May Be Reversible, Study Suggests

The slow march of time is inexorable and irreversible, but that doesn’t mean its effects on our bodies have to be etched in stone.

One of the more intriguing ideas in aging research is that growing old isn’t just a matter of damage accumulating over the years.

It may also be a story of lost information – the gradual breakdown of the molecular instructions that tell cells which genes to use and which to keep quiet.

Multifold increase in spinal inhibitory cell types with emergence of limb movement

Frog metamorphosis reveals how spinal circuits adapt to new motor demands. Vijatovic et al. demonstrate that the shift from tail-to limb-based locomotion coincides with expansion and diversification of V1 inhibitory neurons. Cross-species comparisons identify a conserved blueprint of tail and limb locomotion, with Engrailed-1 a global regulator of movement frequency.

Scientists say they’ve reversed brain aging with a simple nasal spray

Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just two doses, memory and cognitive function improved for months, raising hopes for future treatments targeting dementia and brain fog.

/* */